SuperworthAmneal Pharmaceuticals market cap AMRX
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $6.5B
- Highest close in our data
- $7.2B
- Sep 2018
Amneal Pharmaceuticals is worth $6.5B at the close on Oct 23, 2026, at $20.38 a share.
That is up 96% over the last year and up 293% over five years.
Its highest close in our data was $7.2B in Sep 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6.5B | $3.7B | $6.5B | +60% |
| 2025 | $4.1B | $2.2B | $4.1B | +68% |
| 2024 | $2.4B | $1.7B | $2.7B | +30% |
| 2023 | $1.9B | $403.8M | $1.9B | +208% |
| 2022 | $604.1M | $594.9M | $1.4B | −58% |
| 2021 | $1.4B | $1.2B | $2.1B | +5% |
| 2020 | $1.4B | $858.8M | $1.6B | +2% |
| 2019 | $1.3B | $723.8M | $4.4B | −67% |
| 2018 | $4.1B | $14.7K | $7.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Amneal Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| AMRXAmneal Pharmaceuticals | $6.5B |
| LGNDLigand Pharmaceuticals | $6.1B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| ALKSAlkermes plc. | $7.3B |
| TGTXTG Therapeutics | $8.3B |
| PTGXProtagonist Therapeutics | $9B |
| CORTCorcept Therapeutics | $9.3B |
| INDVIndivior Pharmaceuticals | $4.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| BMRNBiomarin Pharmaceutical | $10.8B |
| LQDALiquidia | $3.8B |
| Peer median | $6.7B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Amneal Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.